GoodBoy Dog Recovery captured a wolf-dog hybrid spotted in Bristol after it managed to evade both animal control and the ...
BMS-986484 is under clinical development by Bristol-Myers Squibb and currently in Phase I for Non-Small Cell Lung Cancer.
(Bloomberg) -- Bristol Myers Squibb Co. raised its 2024 ... will be between 75 cents and 95 cents a share, the Princeton, New ...